RCA
HOWL icon

Ranch Capital Advisors’s Werewolf Therapeutics HOWL Stock Holding History

Ranch Capital Advisors’s Portfolio HOWL Stock Details HOWL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.96K Sell
11,000
-1,000
-8% -$609 ﹤0.01% 157
2026
Q1 		$9.99K Hold
12,000
– – ﹤0.01% 154
2025
Q4 		$7.6K Buy
+12,000
New +$14.6K ﹤0.01% 153

Other funds holding HOWL

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
DF
DC Funds Mclean, Virginia $1.25M AUM 26.51% 1-Year Est. Return
VA
Verdad Advisers Boston, Massachusetts $104M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Ranch Capital Advisors's HOWL Position: Q2 2026 in Review

Ranch Capital Advisors reduced its Werewolf Therapeutics (HOWL) stake by 8.3% in Q2 2026, selling an estimated $609 and leaving 11,000 shares worth $3.96K. The position accounts for ﹤0.01% of the portfolio, ranked #157.

Ranch Capital Advisors first reported a position in HOWL in Q4 2025 and has held it in 3 quarters since. The position peaked at $9.99K in Q1 2026. 45 funds tracked by Wall St. Rank hold HOWL as of Q2 2026.

  • Ranch Capital Advisors held 11,000 shares of Werewolf Therapeutics worth $3.96K as of Q2 2026.
  • Ranch Capital Advisors sold 1,000 Werewolf Therapeutics shares in Q2 2026, an estimated $609.
  • Werewolf Therapeutics made up ﹤0.01% of Ranch Capital Advisors's portfolio in Q2 2026, its #157 holding.
  • Ranch Capital Advisors first reported a position in Werewolf Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • Ranch Capital Advisors's Werewolf Therapeutics position peaked at $9.99K in Q1 2026.
  • 45 funds tracked by Wall St. Rank held Werewolf Therapeutics as of Q2 2026.

Based on Ranch Capital Advisors's 13F filing for Q2 2026, filed 3 Aug 2026.